Order Article Reprints

Koole SN, Vessies DCL, Schuurbiers MMF, Kramer A, Schouten RD, Degeling K, Bosch LJW, van den Heuvel MM, van Harten WH, van den Broek D, et al. Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance. Cancers. 2022; 14(7):1783. https://doi.org/10.3390/cancers14071783

Koole, Simone N., Daan C. L. Vessies, Milou M. F. Schuurbiers, Astrid Kramer, Robert D. Schouten, Koen Degeling, Linda J. W. Bosch, Michel M. van den Heuvel, Wim H. van Harten, Daan van den Broek, and et al. 2022. "Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance" Cancers 14, no. 7: 1783. https://doi.org/10.3390/cancers14071783

Koole, S. N., Vessies, D. C. L., Schuurbiers, M. M. F., Kramer, A., Schouten, R. D., Degeling, K., Bosch, L. J. W., van den Heuvel, M. M., van Harten, W. H., van den Broek, D., Monkhorst, K., & Retèl, V. P. (2022). Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance. Cancers, 14(7), 1783. https://doi.org/10.3390/cancers14071783